Restaurants add protein, fiber for weight loss drug users
A mini burger, mini fries and mini beer, Clinton Hall's "Teeny Weeny Mini Meal", is pictured next to a regular-sized...
HEALTH & FITNESS
How CNBC Cures is bringing rare disease stories to a national audience
Last summer, my sister Becky approached me with an idea. She wanted my help building a platform at CNBC to...
ACA enrollees go uninsured after enhanced subsidies expire: KFF poll
Many Americans are feeling the financial pain following the expiration of enhanced federal subsidies for Affordable Care Act marketplace health...
FDA approves high dose version of Novo Nordisk’s obesity drug Wegovy
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4,...
Stopping GLP-1s raises cardiovascular risks: study
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy.Hollie Adams | ReutersA version of this...
Eli Lilly shares slide after a bearish analyst call — here’s our view
Eli Lilly shares are down 6% Tuesday and on pace for their worst day since February after an HSBC downgrade....
White House chief of staff Susie Wiles diagnosed with ‘early stage breast cancer’: Trump
Susie Wiles, White House chief of staff, in the Oval Office of the White House in Washington, June 27, 2025.Yuri...
FDA approves leucovorin for cerebral folate deficiency but not autism
The Food and Drug Administration on Tuesday approved a decades-old prescription vitamin called leucovorin as the first treatment for a...
Vertex kidney drug povetacicept succeeds in trial for IgAN
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston.Brian Snyder | ReutersVertex Pharmaceuticals said its...
Novo Nordisk ends legal proceedings against Hims & Hers
Novo Nordisk has dropped its legal case against telehealth provider Hims & Hers over patent infringement, after the two companies...
FDA reversals on UniQure, Moderna approvals worry investors
Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from...
FDA official discusses UniQure gene therapy for Huntington’s disease
Thomas Fuller | SOPA Images | Lightrocket | Getty ImagesUniQure needs to run another study to prove that its gene...
We’re dipping into our large cash pile to buy more of this health-care stock
We are buying 90 shares of Cardinal Health at roughly $217. Following the trade, Jim Cramer's Charitable Trust will own...
In cystic fibrosis fight, Boomer Esiason and son Gunnar are winning
As NFL quarterback Boomer Esiason was about to step onto the practice field for the New York Jets in 1993,...
We’ve been active with trades during the Iran war fallout. Jim Cramer explains our approach
Jim Cramer on Tuesday morning explained why the Investing Club is trying to strike a delicate balance with its moves...
Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly
Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its production capacities...
Here’s Jim Cramer’s advice for navigating the markets during the Iran conflict
Jim Cramer's advice for investors navigating fallout from the U.S.-Israeli attack on Iran: Be selective. With stocks initially selling off...
We’re adding a stock to our Bullpen; resistant to recessions, AI disruption
We added a new Bullpen name during Friday's Monthly Meeting, and it has minimal economic sensitivity and faces little to...
Jim Cramer’s update on our AI stocks and the rest of the portfolio
On Friday, the CNBC Investing Club held its February Monthly Meeting, where Jim Cramer and Director of Portfolio Analysis ran...
Trump angering MAHA with glyphosate order gives Democrats an opening
An attendee holds a Make America Healthy Again (MAHA) Moms sign at the end of a press conference announcing of...
